Future Recovery. The Signatories agree that the ability to track and defer costs into a regulatory asset is for accounting purposes only. All questions regarding potential ratemaking treatment of the deferred costs and the materiality thereof are reserved for the Company’s next general rate proceeding. The Signatories reserve the right to review and challenge the Company’s recovery of COVID-19 costs and recommend adjustments in the Company’s next general rate case.
Appears in 2 contracts
Samples: Unanimous Stipulation and Agreement, Stipulation and Agreement
Future Recovery. The Signatories Parties agree that the ability to track and defer costs into a regulatory asset is for accounting purposes only. All questions regarding potential ratemaking treatment of the deferred costs and the materiality thereof are reserved for the Company’s next general pending base rate proceedingproceeding (WR-2020-0344) and a subsequent rate case for deferred items not considered for recovery in WR-2020-0344. The Signatories Parties reserve the right to review and challenge the Company’s recovery deferral of COVID-19 costs and recommend adjustments in the Company’s next applicable general rate case.
Appears in 1 contract
Future Recovery. The Signatories agree that the ability to track and defer costs into a regulatory asset is for accounting purposes only. All questions regarding potential ratemaking treatment of the deferred costs and the materiality thereof are reserved for the Company’s next general rate proceedingproceedings. The Signatories reserve the right to review and challenge the Company’s recovery of COVID-19 costs and recommend adjustments in the Company’s next general rate casecases.
Appears in 1 contract
